PAA 0.00% 19.5¢ pharmaust limited

PharmAust ready to trial monepantel on humans to fight motor neurone disease, page-30

  1. 694 Posts.
    lightbulb Created with Sketch. 1322
    Throughout the interview, it looked to me like Roger was a) pretty tired; and b) being VERY careful about what he said.

    The "other factors...now" comment I believe is vitally important. He's not saying "But we've decided to see if we can rustle up some interest in helping with/shaping the Phase 3." That's in the rear vision mirror now. Nope, this is something tangible that's caused a reconsideration of the trialling strategy that would involve a major player and a licensing agreement - Roger says as much later in the video. And it's happened pretty recently.

    Baby steps, but meaningful steps nonetheless.
    Last edited by Densy: 07/06/22
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
19.5¢
Change
0.000(0.00%)
Mkt cap ! $86.55M
Open High Low Value Volume
19.5¢ 19.5¢ 18.5¢ $330.4K 1.741M

Buyers (Bids)

No. Vol. Price($)
1 4071 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
19.5¢ 24580 3
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.